Animation - Targeted Therapy in NSCLC
Slide Show - Targeted Therapy in NSCLC
1.
What is targeted therapy for lung cancer?
2.
What targeted therapies are used for people with the EGFR mutation?
3.
What targeted therapies are used for people with the ALK mutation?
4.
What targeted therapies are used for people with the ROS1 mutation?
5.
What is the importance of combination therapies for BRAF?
6.
What is the future of combination therapy for lung cancer?
7.
Can biomarker testing help identify clinical trial opportunities for me?
8.
How can communities of color increase their participation in clinical trials?
Expert Video - What is targeted therapy for lung cancer?
Cancer expert Dr. Robert Winn explains that targeted therapy for lung cancer is based on identifying specific mutations in non-small-cell lung cancer that indicate what drug the patient will best respond to. Biomarker testing provides the targets for specific, precision medicine therapies that are more likely than older, non-precision treatments to help patients survive and thrive.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Section: Targeted Therapy in NSCLC
Expert Videos
Animation - Targeted Therapy in NSCLC
Slide Show - Targeted Therapy in NSCLC
1.
What is targeted therapy for lung cancer?
2.
What targeted therapies are used for people with the EGFR mutation?
3.
What targeted therapies are used for people with the ALK mutation?
4.
What targeted therapies are used for people with the ROS1 mutation?
5.
What is the importance of combination therapies for BRAF?
6.
What is the future of combination therapy for lung cancer?
7.
Can biomarker testing help identify clinical trial opportunities for me?
8.
How can communities of color increase their participation in clinical trials?
